Frazier Lifesciences Acquisition Corp

Frazier Lifesciences Acquisition Corp (Nasdaq: FLAC) is a blank check company sponsored by Frazier Life Sciences, LLC, the life sciences affiliate of Frazier Healthcare Partners, a healthcare-focused investment firm with a long track record in biotechnology and pharmaceutical investing. FLAC completed its initial public offering in January 2021, targeting acquisition candidates in the life sciences sector, including biopharmaceuticals, medical technology, and related healthcare services. The company filed its annual report on Form 10-K with the SEC on March 25, 2022, covering fiscal year 2021, during which it continued its search for a qualifying business combination. Visit SpacDesk and sign up for full data, filings, and deal timelines on FLAC and hundreds of other SPACs.